None
Quote | Kane Biotech (OTCMKTS:KNBIF)
Last: | $0.0975 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0975 |
Close: | $0.0975 |
High: | $0.0975 |
Low: | $0.0975 |
Volume: | 7,000 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Kane Biotech (OTCMKTS:KNBIF)
WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...
2024-07-11 08:41:57 ET More on Kane Biotech Financial information for Kane Biotech Read the full article on Seeking Alpha For further details see: Kane Biotech signs license deal with Omni Bioceutical for its scalp care products
Message Board Posts | Kane Biotech (OTCMKTS:KNBIF)
Subject | By | Source | When |
---|---|---|---|
This is the year. Lets go! :) | J_Dean | investorshub | 04/29/2021 8:40:58 PM |
Kane Biotech Announces Third Quarter 2019 | Golden Cross | investorshub | 02/16/2020 9:58:25 PM |
$KNBIF Website: | Golden Cross | investorshub | 02/16/2020 9:34:01 PM |
Kane Biotech is a biotechnology company engaged in | Golden Cross | investorshub | 02/16/2020 9:32:53 PM |
Monster # of filings today $KNBIF | Golden Cross | investorshub | 02/16/2020 9:28:05 PM |
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations Inc. (“Omni”) for its c...
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”...